pyrazines has been researched along with Leishmaniasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, S; Baratte, B; Bazin, MA; Bernadat, G; Cavé, C; Cojean, S; Le Pape, P; Leclercq, O; Loiseau, PM; Marchand, P; Morgado, C; Nourrisson, MR; Ourliac-Garnier, I; Pagniez, F; Picot, C; Rachidi, N; Robert, T; Späth, GF | 1 |
| Ospina-Villa, JD; Soto-Sánchez, J | 1 |
1 review(s) available for pyrazines and Leishmaniasis
| Article | Year |
|---|---|
Current status of quinoxaline and quinoxaline 1,4-di-N-oxides derivatives as potential antiparasitic agents.
Topics: Animals; Antiparasitic Agents; Benzene; Chagas Disease; Humans; Leishmaniasis; Malaria; Oxidation-Reduction; Oxides; Pyrazines; Quinoxalines; Structure-Activity Relationship | 2021 |
1 other study(ies) available for pyrazines and Leishmaniasis
| Article | Year |
|---|---|
In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition.
Topics: Casein Kinase I; Humans; Imidazoles; Leishmania major; Leishmaniasis; Models, Molecular; Protein Kinase Inhibitors; Pyrazines; Trypanocidal Agents | 2021 |